(Q44540672)

4 December 2017

title

TRAIL/Apo2L ligands induce apoptosis in malignant rhabdoid tumor cell lines (English)

1 reference

4 December 2017

1 reference

Shinobu Yoshida

1

1 reference

4 December 2017

Tsutomu Narita

2

1 reference

4 December 2017

Shigeki Koshida

3

1 reference

4 December 2017

Shigeru Ohta

4

1 reference

4 December 2017

Yoshihiro Takeuchi

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

6 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

54

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

709-717

1 reference

Histopathology and prognosis of Wilms tumorResults from the first national wilms' tumor study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Malignant rhabdoid tumor of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Primary rhabdoid tumour of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Malignant rhabdoid tumor of the pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

APO2 ligand: a novel lethal weapon against malignant glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Regulation of cell death protease caspase-9 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Extrarenal rhabdoid sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Malignant rhabdoid tumor. A morphological and flow cytometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Paravertebral malignant rhabdoid tumor in infancy. In vitro studies of a familial tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

How TRAIL kills cancer cells, but not normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Functional expression of TRAIL by lymphoid and myeloid tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

Inhibition of fas death signals by FLIPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000085038.53151.D0

10.1203/01.PDR.0000085038.53151.D0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

4 December 2017

1029010654

0 references

1 reference